Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Feb 11, 2020

Ulf Jungnelius MD, CEO, Isofol Medical discusses the increasing incidence of colorectal cancer as a global issue and the current challenges in treating this devastating disease.  Dr. Jungnelius also talks about the company's drug candidate, arfolitixorin, currently being studied in a global Phase 3 clinical trial with...


Feb 11, 2020

Ulf Jungnelius MD, CEO, Isofol Medical discusses the increasing incidence of colorectal cancer as a global issue and the current challenges in treating this devastating disease.  Dr. Jungnelius also talks about the company's drug candidate, arfolitixorin, currently being studied in a global Phase 3 clinical trial with...


Feb 10, 2020

Purnanand Sarma, CEO, Immunome discusses why a lot of cancers still remain untreatable today and the company's new approach to fight cancer by tapping into the body's natural immune response against disease.  Sarma further talks about why Immunome chose to look at cancer through the lens of the B-cell in order to...


Feb 10, 2020

Purnanand Sarma, CEO, Immunome discusses why a lot of cancers still remain untreatable today and the company's new approach to fight cancer by tapping into the body's natural immune response against disease.  Sarma further talks about why Immunome chose to look at cancer through the lens of the B-cell in order to...


Jan 29, 2020

Anat Cohen-Dayag PhD chief executive officer, Compugen discusses the current immune-oncology treatment landscape, with only 20-30% of patients responding to currently available treatments, and the missing link that she believes her company may have found to improve the success rate.  Anat talks about how Compugen's...